Royal Pharmaceutical Society (RPS) Scotland has submitted its evidence to the Health, Social Care and Sport Committee's inquiry into 'Healthcare in remote
and rural areas.'
The Committee had sought views on what policies and actions would be most effective in addressing the issues people face when accessing healthcare in these areas.
During the evidence session today (19 December), Laura Wilson, Director for RPS Scotland, highlighted the challenges faced by pharmacists and pharmacy in remote and
rural areas, as well as provided some of the solutions for ensuring a sustainable pharmacy workforce.
At present, people living in remote and rural areas of Scotland are required to travel to Glasgow or Aberdeen to undertake pharmacy training. Laura underscored the
need to develop alternative education and training pathways, such as "grow your own" models, to support remote and rural areas to develop and retain local pharmacists.
The fusion of the unique in-depth understanding of medicines by pharmacists together with the competence to prescribe offers will improve access to care and
increase capacity in the health system, said the Royal Pharmaceutical Society (RPS) Director for England Ravi Sharma to Parliament at the Health and Social Care
Select Committee's inquiry on workforce on Monday (May 23).
However, he also stated that a new workforce strategy must support and harness the skills of pharmacist independent prescribers in clinical care with investment
in training, both for new and existing workforce; access to supervisors; protected learning and development time; and commissioning of services to make best use of
independent prescribers across care settings, supported by appropriate prescribing budgets in community pharmacy.
"We're about to see new generation of pharmacists independent prescribers that will make a huge difference to the clinical role of pharmacists to support patient care, but this must be underpinned by protected learning time and a more ambitious approach to commissioning new services to use their skills," Ravi said.
He spoke to MPs in Parliament at the Health and Social Care Select Committee's inquiry on workforce, highlighting the vital contribution of pharmacy teams during
the pandemic and called for action to support the current and future workforce.
Some of the key issues highlighted in the parliament included, the risk of burnout and the need to help boost staff retention; staff wellbeing, including a zero tolerance of abuse from the public; the importance of professional development and protected learning time to enhance patient care and support rewarding careers; the potential of new pharmacist independent prescribers and the need for investment in the current workforce and the need for better workforce data and a pharmacy workforce strategy.
The Royal Pharmaceutical Society (RPS) presented the best practice award to a pharmacist from NHS Tayside at an event on May 29 which celebrated pharmacy
practice across Scotland.
The Glasgow event, organised by RPS, brought together pharmacists from across the country to present their own best-practice examples.
These included all sectors of pharmacy, including hospital, GP practices, community and specialist settings.
Delegates at the event were asked to vote for what they considered to be the winning example of best practice. Alex Matos, specialist clinical pharmacist, won the
award for his presentation on 'Implementing Pharmacogenomics in the Stroke Service'.
Alex won a £500 bursary for travel and accommodation to the RPS's annual conference in London, where he has been invited to present on his best practice example.
The Royal Pharmaceutical Society (RPS) has launched a partnership with the charity Marie Curie to develop professional standards in end of life care for community pharmacy.
Available for pharmacy teams across the UK, the standards will provide a free, evidence-based framework to help community pharmacies self-assess and continuously improve their end of life and bereavement care for patients and carers.
They will enable community pharmacy teams to work together to develop their own practice.
RPS is setting up a professional standard steering group which will have community pharmacy experts, experts within the field of palliative and end of life care,
lay members, and healthcare professionals who interact with community pharmacy.
Elen Jones, director lead for palliative care work at RPS, said: "RPS has a long-term commitment, striving to ensure that people living with life-limiting conditions
who are approaching the end of life have timely access to medicines and clinical support from a skilled pharmacy team.
"The development of these standards, in partnership with Marie Curie, is a crucial step to support community pharmacy teams to undertake simple quality improvement
measures and build upon the care they already provide to this group of patients and carers."
Catriona Sinclair, a community pharmacist in the Highlands with over thirty years' experience, has been elected vice-chair of the Royal Pharmaceutical Society
(RPS)'s Scottish Pharmacy Board.
As the incoming vice-chair, she will sit on the RPS's assembly which is responsible for setting the strategic direction of the Society.
Audrey Thompson, lead pharmacist for Prescribing in NHS Greater Glasgow and Clyde, with over twenty-five years' experience in primary care, was elected to RPS
Assembly.
The newly formed board has three new faces - Josh Miller, Richard Shearer and Jill Swan. In addition, the Board co-opted Kelsey Drummond to a newly created early
career pharmacist place.
There are also three departing board members: Dr Brian Addison, Kathleen Cowle and John McAnaw.
The Royal Pharmaceutical Society (RPS) has published its general election manifesto highlighting some of the key challenges the next Government will face to
support patients and the NHS.
The manifesto calls on general election candidates to show their support to securing patient access to medicines, a better-connected NHS, enhancing accessible
prescribing in local communities, and maximising health improvement through locally accessible pharmacy teams.
Candidates are urged to called on the next Government, if elected, to support the pharmacy workforce to deliver patient care, unlock the potential of new advances
in medicines, and continue to support funding for the UK science and research community.
The manifesto highlights the need for investment in IT infrastructure to support a better-connected NHS to enable all health professionals to access and update a
patient's record.
The Royal Pharmaceutical Society in England (RPS) and Community Pharmacy England (CPE) have raised alarm over the impending increase in NHS prescription
charges, slated to take effect from May 1, 2024.
The RPS, represented by Chair Tase Oputu, condemned the rise, labeling it a "dark day for patients" who will now face nearly £10 per prescription item.
Oputu emphasised the disproportionate impact on individuals with low incomes, citing the "relentless annual increases in prescription charges" as exacerbating
the affordability crisis in healthcare.
" Every day pharmacists are asked by patients who are unable to afford all the items in their prescription which ones they can 'do without'" she said.
She further added that the financial barriers to get vital medicines should not be faced by any one and advocated for "the abolition of prescription charges in
England, as has been implemented in other parts of the UK".
Responding to a new National Audit Office (NAO) report that indicated that NHS England's Long Term Workforce Plan (LTWP) needs improvements, the Royal
College of General Practitioners (RCGP) has expressed concerns that the plan may not adequately address the needs of GPs.
Published in June 2023, the workforce plan estimated that the NHS's health workforce will need to grow from 1.4m full-time equivalent (FTE) staff in 2021-22 to
between 2.3m and 2.4m FTE workers in 2036-37, an increase of 65 per cent to 72 per cent.
However, the NAO report highlighted that the workforce modelling has significant weaknesses, including a complex design; manual adjustments; optimistic future
assumptions and limited public communication of their uncertainty; and modelling outputs that could not be fully replicated.
To improve the modelling, the report recommended exploring the uncertainty of these assumptions and considering potential outcomes if they do not materialize as
expected. Additionally, it suggested including full integration of the different parts of the modelling pipeline to minimise manual adjustments.
Recognising her remarkable contribution in the profession of pharmacy, Christine Gilmour, the Director of Pharmacy at NHS Lanarkshire, has been designated
as a Fellow of the Royal Pharmaceutical Society (RPS).
Christine, who joined NHS Lanarkshire as trust chief pharmacist for University Hospital Hairmyres and Stonehouse in 1994. She has been in her current role as
Director of Pharmacy for 17 years now.
Considered to be one of the highest accolades in the domain of pharmacy, this fellowship recognises the distinction of an RPS member in the pharmacy career.
NHS Lanarkshire executive medical director, Dr Chris Deighan commented: "We are extremely proud of Christine. This is a fantastic achievement and recognises
all the hard work, dedication and expertise Christine has displayed across her career."
Professor Ryan Donnelly, esteemed for his groundbreaking contributions to pharmaceutical science, has been awarded the prestigious Royal Pharmaceutical
Society (RPS) Harrison Memorial Medal for 2024.
This distinguished accolade, presented in honour of the renowned pharmaceutical chemist Col EF Harrison, serves as a testament to Professor Donnelly's exceptional
achievements.
Currently holding the position of Chair in Pharmaceutical Technology at Queen's University Belfast's School of Pharmacy and Director of Research, Professor Donnelly
has garnered acclaim for his pioneering work in developing advanced polymeric drug delivery systems.
Specialising in transdermal and intradermal drug delivery methodologies, his research aims at optimising patient outcomes through innovative pharmaceutical
technologies.
The Royal Pharmaceutical Society (RPS), professional membership body for pharmacists and pharmacy, has published its manifesto for the general election,
highlighting key issues facing the next government after the election on July 4.
Local candidates are urged to recognise and support the vital role pharmacists play in supporting people's health.
The RPS teams are gearing up to influence government policy in various crucial areas. Their key asks include:
Ensuring Secure Patient Access to Medicines
Supporting a Better-Connected NHS
Enhancing Accessible Prescribing in Local Communities
Maximizing Health Improvement through Locally Accessible Pharmacy Teams
Supporting the Workforce to Deliver Patient Care
Unlocking the Potential of New Advances in Medicines
Supporting the UK's Global Position in Science and Research
Acknowledging the efforts of pharmacists and their teams, Professor Claire Anderson, President of the RPS, noted that they are "working incredibly hard to
maintain patient access to care amid workforce challenges, medicines shortages and financial pressures."
The Royal Pharmaceutical Society (RPS) recently announced a valuable addition to their e-library collection: the Maudsley Deprescribing Guidelines,
authored by renowned experts Mark Horowitz and David Taylor.
Designed to assist pharmacists and clinicians in recognising and appropriately treating withdrawal effects of medications, the guidelines have garnered praise
from industry figures like Peter Pratt, National Speciality Advisor for Mental Health Pharmacy and RPS Fellow.
This initiative responds to the increasing demand for guidance on safely reducing or discontinuing psychiatric medications, providing comprehensive support for
clinicians and patients alike.
Drawing on insights from contributors to The Lancet Psychiatry, the handbook offers step-by-step instructions for tapering antidepressants, benzodiazepines,
gabapentinoids, and z-drugs, along with troubleshooting strategies.
Expressing its concerns over the Government's decision to make Covid-19 vaccines mandatory for health workers in England, the Royal Pharmaceutical Society (RPS) has said an "informed choice" is better than compulsory vaccination.
Health secretary Sajid Javid said today (Nov 9) that health workers in England will have to be vaccinated against Covid-19 by April 1, 2021, making it a mandatory condition of employment for those on the frontline of the NHS.
"All those working in the NHS and social care will have to be vaccinated. We must avoid preventable harm and protect patients in the NHS, protect colleagues in the NHS and of course protect the NHS itself," Javid told parliament.
The RPS said it "strongly encourages all pharmacists to take advantage of the Covid-19 vaccination programme and to get vaccinated unless there is a medical reason not to do so". It belies that "this is best practice" and part of the pharmacists' responsibility to act in the best interest of their patients.
All four UK health services have committed to net zero carbon emissions, health secretary Sajid Javid announced today (November 9).
Lauding the commitment, Javid said: "As a health community, we cannot simply sit on the sidelines - we must respond to climate change through urgent action, with global collaboration at its core."
Health systems in the UK have already started work on being greener.
On behalf of the profession, Royal Pharmaceutical Society (RPS) joined the International Pharmaceutical Federation (FIP) in writing a letter to world leaders
who had gathered in Glasgow earlier last week to attend the COP26 summit, expressing pharmacy's commitment to tacking the climate crisis.
RPS also signed a charter to guide effective and high-quality climate action by professional bodies in the UK.
Community pharmacy contractors will start receiving materials for the winter vaccines campaign via Royal Mail from today (November 8).
It is the second mandated health campaign for 2021/22 in which contractors must participate as part of their NHS contractual requirements, after the NHS England and NHS Improvement and Pharmaceutical Services Negotiating Committee (PSNC) reached an agreement.
The campaign pack, to be arrived in pharmacies, includes a briefing sheet; four A4 posters; one Q&A leaflet; and one A6 shelf wobbler along with social media and digital resources.
PSNC has also reminded contractors to have "an action plan" promote Covid-19 vaccinations, particularly in Black, Asian and minority ethnic and low uptake communities.
The Royal Pharmaceutical Society is set to cease all its remaining financial investments in fossil fuels latest by the end of 2022.
The decision taken today (November 17) at the RPS Assemble, is part of the organisation's "continued drive to become an environmentally responsible organisation."
Calling it a significant move, RPS president Claire Anderson said: "RPS will divest from fossil fuels as soon as possible.
"RPS will instruct its investment managers immediately to ensure that we will be completely disinvested by the end of 2022 and hopefully sooner."
Environment and human wellbeing have always been a core consideration of RPS investment, however it was not enough to offset the negative impacts of climate change, the organisation said.
There is still a long way to go to achieve gender equality in pharmacy in both academia and profession, Royal Pharmaceutical Society president Claire Anderson
said while addressing a webinar on 'Driving equality for women in pharmacy' today (November 19).
Sharing her personal experience, Anderson, who earlier worked as an academic, said: "I was the first ever female professor in the School of Pharmacy at Nottingham
when I was appointed as professor in 2003, and at that point, only 11 per cent of professors in my university were female."
She acknowledged that the situation has changed since then, but "there's still a very long way to go to achieve gender equity in most of academia, and in pharmacy,
in particular."
She added that the profession has ensured safe spaces for women but noted that is not enough, as gender equity is vital to achieve healthier and safer societies.
"And although our work on equality, diversity and inclusion is progressing very well, I think we're still not there. It's a journey and there's much to be achieved."
The Royal Pharmaceutical Society (RPS) has welcomed the Health Secretary Sajid Javid's plan to appoint Hormone Replacement Therapy (HRT) tsar to tackle the medicine shortages.
On Sunday (April 24) Sajid Javid told the Mail that he planned to tackle the problem (shortage of HRT medicine) by appointing a new HRT tsar with the role modelled on that of Kate Bingham, who successfully led the government's Covid vaccine taskforce.
"The difficulties in accessing HRT medicine have unfairly impacted women's mental health," said RPS President, Professor Claire Anderson.
"I look forward to working with this new champion for HRT and the Government on how we can better support women's health, building on the positive move to reduce
prescription charges for HRT for women."
Anderson also stressed that "the Government should now go further and end unfair prescription charges for patients in England altogether."
In an open letter to pharmacy colleagues, the Royal Pharmaceutical Society (RPS) praised the work being done by them over this "extremely busy period."
Expressing gratitude towards pharmacists RPS said "Patients rely on you and we are so proud of the work you are doing."
It said the incredible work of pharmacists, in all settings, have ensured that patients have access to medicines and advice during the pandemic.
Calling pharmacists an integral part of the profession, RPS said they not only prescribe and advise the public, but also play a key role in teaching future pharmacists, developing new medicines, running and supporting clinical trials.
The Royal Pharmaceutical Society (RPS) has decided to lease two floors of its east London headquarters to Ingeus, a business with services in employment, health, justice and youth.
RPS will retain three floors of the building, including its museum and library on the ground floor, as well as the two upper floors which will be used for events, collaborative working and team meetings.
The decision follows an announcement in April that the the Society was re-evaluating whether it needed to hold on to its current office space as homeworking was becoming the norm due to the Covid-19 pandemic. The Society also wanted to maximise value from its property and generate additional revenue which could "be
reinvested into further developing our valued products and services".
Ingeus runs the government-sponsored Restart Scheme to help people find jobs in their local area.